ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pulmonary"

  • Abstract Number: L07 • ACR Convergence 2024

    The Classification Criteria for Anti-Synthetase Syndrome (Class) Project

    Giovanni Zanframundo1, Sara Faghihi Kashani2, Akira Yoshida3, Eduardo Dourado4, Iazsmin Bauer Ventura5, Daphne Rivero Gallegos6, Aravinthan Loganathan7, Gianluca Sambataro8, Francisca Bozan9, Sangmee Bae10, Darosa Lim11, Marta Cheli12, Yasuhiko Yamano13, Francesco Bonella14, Tamera Corte15, Tracy J. Doyle16, David Fiorentino17, Miguel Gonzalez-Gay18, Marie Hudson19, Masataka Kuwana20, Ingrid Lundberg21, Andrew Mammen22, Neil McHugh23, Frederick Miller24, Carlomaurizio Montecucco1, Chester Oddis25, Jorge Rojas-Serrano6, Jens Schmidt26, Carlo Alberto Scirè27, Albert Selva-O'Callaghan28, Victoria Werth11, Davide Rozza29, Monica Morosini30, Sara Bozzini30, Lorenzo Cavagna1, Rohit Aggarwal25 and the CLASS project investigators, 1Università di Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, 2University of Pittsburgh School of Medicine, Pittsburgh, PA, USA and University of California, San Francisco, CA, 3Nippon Medical School Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan, 4Unidade Local de Saùde da Regiao de Aveiro and Aveiro Rheumatology Research Centre, Aveiro, Portugal; Universidade de Lisboa, Lisboa, Portugal, 5University of Chicago, Chicago, IL, 6Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Mexico City, Mexico, 7Royal National Hospital for Rheumatic Diseases and University of Bath, UK; Arthritis Australia, Broadway, Glebe, NSW, Australia, 8University of Enna "Kore", Enna, Italy, 9Hospital Clinico Universidad de Chile, Santiago de Chile, Chile, 10UCLA, Los Angeles, CA, 11University of Pennsylvania, Philadelphia, PA, 12Fondazione IRCCS Istituto Neurologico C. Besta, Milano, Italy, 13Tosei General Hospital, Aichi, Japan, 14University of Duisburg-Essen, Essen, Germany, 15Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia, 16Brigham and Women's Hospital, Boston, MA, 17Stanford University, Redwood City, CA, 18IIS-Fundación Jiménez Díaz, Madrid, Spain, 19McGill University, Montreal, QC, Canada, 20Nippon Medical School Graduate School of Medicine, Tokyo, Japan, 21Karolinska Institutet, Stockholm, Sweden, 22NIH, Bethesda, MD, 23University of Bath, Bath, United Kingdom, 24NIH, NIEHS, Durham, NC, 25University of Pittsburgh, Pittsburgh, PA, 26University Medical Center Goettingen, Goettingen, Germany, 27Univeristy of Milano Bicocca, Milan, Italy and IRCCS San Gerardo dei Tintori Foundation, Monza, Italy, 28Hospital Universitari Vall d'Hebron, Barcelona, Spain, 29Italian Society for Rheumatology, Milano, Italy, 30Fondazione IRCCS Policlinico San Matteo Hospital of Pavia, Pavia, Italy

    Background/Purpose: The aim of this study was to develop and validate new classification criteria for Anti-Synthetase Syndrome (ASSD) using data and consensus driven methodologies and…
  • Abstract Number: 0331 • ACR Convergence 2024

    Cardiac Manifestations in Patients with Anti-Synthetase Syndrome: Analysis from the “Classification Criteria for Anti-synthetase Syndrome (CLASS)” Project Database

    Sangmee Bae1, Gianluca sambataro2, iazsmin Ventura3, Francisca Bozan4, Eduardo Dourado5, Sara Faghihi-Kashani6, Aravinthan Loganathan7, Daphne Rivero Gallegos8, Akira Yoshida9, Giovanni Zanframundo10, Francesco Bonella11, Tamera J Corte12, Tracy J Doyle13, david fiorentino14, Miguel Angel Gonzalez-Gay15, marie Hudson16, Masataka Kuwana17, Andrew Mammen18, Neil McHugh19, Frederick Miller20, Carlomaurizio Montecucco21, Antonella Notarnicola22, Chester Oddis23, Jorge Rojas-Serrano24, Jens Schmidt25, Carlo A. Scire26, Albert Gil-Vila27, Victoria Werth28, Lorenzo Cavagna29 and Rohit Aggarwal30, 1UCLA, Los Angeles, CA, 2University of Catania, Catania, Italy, 3Section of Rheumatology, University of Chicago, Chicago, IL, 4Hospital Clinico Universidad de Chile, Santiago, Chile, 5Unidade Local de Saúde da Região de Aveiro, Aveiro, Portugal, 6Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, San Francisco, CA, 7Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 8INER, Ciudad de México, Mexico State, Mexico, 9Nippon Medical School Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan, 10Università di Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, Milano, Italy, 11Center for interstitial and rare lung diseases, Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany, 12Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia, 13Brigham and Women's Hospital, West Roxbury, MA, 14Department of Dermatology, Stanford University School of Medicine, Stanford, CA, Palo Alto, CA, 15University of Cantabria, Fundación Jimenez Díaz, Madrid, Madrid, Spain, 16McGill University, Montreal, QC, Canada, 17Department of Allergy and Rheumatology, Nippon Medical School, Tokyo, Japan, Tokyo, Japan, 18NIH, Bethesda, MD, 19University of Bath, Bath, United Kingdom, 20NIH, NIEHS, Chapel Hill, NC, 21IRCCS policlinico S. Matteo foundation, University of Pavia, Pavia, Italy, 22Karolinska University Hospital and Karolinska Institutet, Stockholm, Stockholms Lan, Sweden, 23Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 24National Institute of Respiratory Diseases, Ismael Cosío Villegas, Mexico City, Mexico, 25University Medical Center Goettingen, Göttingen, Germany, 26University of Milano Bicocca, Milan, Italy, 27Universitat Autònoma of Barcelona, Barcelona, Spain, 28University of Pennsylvania, Wynnewood, PA, 29University of Pavia and Fondazione IRCCS Policlinico San Matteo Hospital of Pavia, Pavia, Pavia, Italy, 30Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA

    Background/Purpose: The prevalence of cardiac manifestations has not been comprehensively described in anti-synthetase syndrome (ASSD). In the current study, we report the prevalence of cardiac…
  • Abstract Number: 1501 • ACR Convergence 2024

    Retrospective Cohort Study Identifying Pulmonary Complications in a Cohort of Patients with Systemic Lupus Erythematosus

    Jessica Johnson1, Chao Zhang2 and Emily Littlejohn3, 1Cleveland Clinic Lerner College of Medicine, Cleveland, OH, 2Cleveland Clinic, Cleveland Heights, OH, 3Cleveland Clinic, Cleveland, OH

    Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with multi organ involvement. One of the most common manifestations is pulmonary disease with a…
  • Abstract Number: 2447 • ACR Convergence 2024

    Features of Anti-Fibrillarin Positive Systemic Sclerosis Patients and Ethnic Differences: A European Multicenter Cohort

    Roberto D'Alessandro1, Stefano Rodolfi2, Alix Calot1, Louis Bébéar3, Corrado Campochiaro4, Veronica Codullo5, Francesco Del Galdo6, Ivan Castellvi Barranco7, Elisabetta Zanatta8, Silvia Bellando Randone9, Goncalo Boleto10, Loic Raffray11, Emmanuel Chatelus12, Patrice Cacoub13, Alexandre Le Joncour13, Paolo Airò14, cristiana sieiro santos15, Alain Lescoat16, Jérôme Avouac17, Christopher Denton18 and Yannick Allanore19, 1Rheumatology Department, Cochin Hospital, Université Paris Cité, APHP, Paris, France, Paris, France, 2Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases, University College London, London, UK, London, United Kingdom, 3Department of Rheumatology, Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin, Bordeaux, France., Bordeaux, France, 4IRCCS San Raffaele Hospital. Vita-Salute San Raffaele University, Milan, Milan, Italy, 5Division of Rheumatology - Policlinico San Matteo, Pavia, Italy, Pavia, Lombardia, Italy, 6University of Leeds, Leeds, United Kingdom, 7Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 8Unit of Rheumatology, Padova University, Padova, Italy, 9Department of Experimental and Clinical Medicine University of Florence Division of Rheumatology Scleroderma Unit, Careggi Hospital Florence, Italy, Florence, Toscana, Italy, 10Rheumatology Department, Unidade Local de Saúde Santa Maria, Centro Académico de Medicina de Lisboa, Lisboa, Portugal., Lisbon, Portugal, 11CHU La Réunion - Competence center for autoimmune diseases, Internal Medicine, Saint-Denis, Reunion, 12Rheumatology department strasbourg, Strasbourg, France, 13Department of Internal Medicine and Clinical Immunology France, Centre national de référence maladies Autoimmunes Systémiques rares, Centre national de référence maladies Autoinflammatoires et Amylose, and Inflammation-Immunopathology-Biotherapy Department (DMU i3), Sorbonne Université, AP-HP, Hôpital Pitié Salpetrière, 75013 Paris, France, Paris, France, 14Scleroderma Unit, Rheumatology and Clinical Immunology Unit, ERN ReCONNET, ASST Spedali Civili, Brescia, Italy, Brescia, Italy, 15Rheumatology Department, Complejo Asistencial Universitario de León, León, Spain, Leon, Spain, 16Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France, rennes, France, 17Rheumatology A Department, Hôpital Cochin, AP-HP Centre - Université Paris Cité, Paris, France, 18University College London, Northwood, United Kingdom, 19Rheumatology department, Université Paris Cité, Cochin Hospital of Paris; France, Paris, France

    Background/Purpose: Anti-fibrillarin (AFA) auto-antibodies are rarely found in Systemic Sclerosis (SSc). Beyond the ethnic association with a higher prevalence in patients of Black ethnicity, the…
  • Abstract Number: 0333 • ACR Convergence 2024

    Predictors of Transplant-Free Survival in Idiopathic Inflammatory Myopathies- associated Interstitial Lung Disease

    shiri keret1, Raisa Silva2, Irada Choudhuri2, Eugenia Gkiaouraki3, Tanya Chandra4, Nantakarn Pongtarakulpanit5, shreya Sriram3, silvia Martinez Laverde3, Dana Ascherman3, Siamak Mogahadam5, Chester Oddis5 and Rohit Aggarwal6, 1Rheumatology unit, Bnai-Zion medical center and the faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel., Atlit, Israel, 2Internal medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, 3Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, 4University of Pittsburgh Medical Center, Pittsburgh, PA, 5Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 6Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA

    Background/Purpose: Lung involvement is the most common and severe extra-muscular manifestation of Idiopathic Inflammatory Myopathies (IIM). Early identification of patients at risk for lung transplant…
  • Abstract Number: 1517 • ACR Convergence 2024

    Diagnostic Performance of Anti-dsDNA Antibodies in Pleural, Ascitic and Pericardial Fluid for Lupus Serositis: Experience of a Tertiary Center in Mexico

    Marlon Sandino-Bermúdez1, Erik Cimé-Aké2, Jonathan Campos-Guzmán3, Eduardo Briones-García4, Emilio G. Lazarini2, Carlos Núñez-Álvarez5 and Hilda Fragoso-Loyo2, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Mexico City, Distrito Federal, Mexico, 2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Immunology and Rheumatology Department, Mexico City, Mexico, 3Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 4Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Immunology and Rheumatology Department., Ciudad de México, Distrito Federal, Mexico, 5Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, CDMX, Mexico, Mexico, Mexico

    Background/Purpose: The diagnosis of serositis in systemic lupus erythematosus (SLE) relies on combining clinical and serological data, alongside imaging studies. The aim of this study…
  • Abstract Number: 2465 • ACR Convergence 2024

    Subclinical Loss of Lung Volumes in Very Early SSc: Evidence from Two Independent Cohorts in EUSTAR

    Vishal Kakkar1, Stefano Di Donato2, Silvia Bellando-Randone3, Riccardo Bixio4, Marco Matucci-Cerinic5, Yannick Allanore6 and Francesco Del Galdo1, 1University of Leeds, Leeds, United Kingdom, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds, UK, Leeds, United Kingdom, 3University of Florence, Florence, Florence, Italy, 4University of Verona, Verona, Verona, Italy, 5University San Raffaele Milano, Milano, Milan, Italy, 6Université Paris Cité, Paris, France

    Background/Purpose: Interstitial lung disease (ILD) remains as the major driver of mortality in systemic sclerosis (SSc). The literature indicates that at the time of diagnosis…
  • Abstract Number: 0648 • ACR Convergence 2024

    Prevalence of Pulmonary Complications Among Patients with Systemic Lupus Erythematosus (SLE): A Systematic Review and Meta-analysis

    Athanasios Vassilopoulos1, Stephanos Vassilopoulos2, Jasneet Singh2, Ingrid Lazaridou2, Markos Kalligeros2, Eleftherios Mylonakis3 and Anthony M. Reginato4, 1Warren Alpert Medical School of Brown University, Providence, RI, 2Division of Internal Medicine, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, Rhode Island, Providence, RI, 3Department of Medicine, Houston Methodist Hospital, Houston, 4Brown University, Providence, RI

    Background/Purpose: Pleuritis remains the most common pulmonary manifestation in patients with SLE.  The prevalence of other less common complications of SLE such as: interstitial lung…
  • Abstract Number: 1528 • ACR Convergence 2024

    Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: National Inpatient Sample Analysis

    Maria Romero Noboa1, Almurtada Razok2, Husam El Sharu3 and Rafaella Litvin2, 1University of Alabama at Birmingham, Chicago, IL, 2John H Stroger Jr Hospital of Cook County, Chicago, IL, 3East Carolina University, Greenville, NC

    Background/Purpose: Systemic Lupus Erythematosus (SLE) can lead to a range of pulmonary complications, including Pulmonary Arterial Hypertension (PAH), which affects between 0.5% and 17.5% of…
  • Abstract Number: 2492 • ACR Convergence 2024

    ANCA Associated Tracheobronchial Disease

    Megan Sullivan1, Maximiliano Diaz Menindez2, Ronald Butendieck3, hassan baig4, Anushka Irani5, Benjamin Wang3, Florentina Berianu5, Carolyn Mead-Harvey6, Andy Abril5 and Vikas Majithia4, 1Mayo Clinic Arizona, Scottsdale, AZ, 2Mayo Clinic School of Graduate Medical Education, Phoenix, AZ, 3Mayo Clinic, Jacksonville, FL, 4Mayo Clinic Florida, Jacksonville, FL, 5Mayo Clinic, Ponte Vedra Beach, FL, 6Mayo Clinic, Scottsdale, AZ

    Background/Purpose: Tracheobronchial disease is a common manifestation of ANCA associated vasculitis (AAV). However, outcomes data is commonly unreported in prospective studies. We performed a retrospective…
  • Abstract Number: 0678 • ACR Convergence 2024

    Patients with Interstitial Lung Disease Due to Systemic Sclerosis or Rheumatoid Arthritis Need Monitoring More Frequently Than Annually

    Oliver Distler1, Margarida Alves2, Gerrit Toenges3 and Anna-Maria Hoffmann-Vold4, 1Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, Zurich, Switzerland, 2Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany, Ingelheim, Germany, 3Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany, Ingelheim am Rhein, Germany, 4Oslo University Hospital, Oslo, Norway

    Background/Purpose: There is no consensus on the frequency of monitoring of patients with autoimmune disease-related interstitial lung diseases (ILDs), but a frequency of 1 year…
  • Abstract Number: 1559 • ACR Convergence 2024

    Vectorcardiography for Identification of Systemic Sclerosis Patients at Risk for Pulmonary Hypertension

    S. Ahmed1, Eva Hoekstra2, Katie van der Wouden2, Sum-Che Man2, Kees Swenne2, Madelon Vonk3, Anna-Maria Hoffmann-Vold4, Cosimo Bruni5, Udo Mulder6, Thomas Huizinga7, H.W. Vliegen2 and Jeska de Vries-Bouwstra2, 1Leiden University Medical Centre, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 4Oslo University Hospital, Oslo, Norway, 5University of Zurich, Zurich, Switzerland, 6Universitair Medisch Centrum Groningen, Groningen, Netherlands, 7Department of Rheumatology, Leiden University, Leiden, Netherlands

    Background/Purpose: Pulmonary hypertension (PH) in SSc causes significant disease burden and requires invasive diagnosis with right heart catheterization (RHC). Comprehensive work-up is needed to identify…
  • Abstract Number: 2495 • ACR Convergence 2024

    Diffuse Alveolar Hemorrhage in Patient with ANCA-associated Vasculitis AndInterstitial Lung Disease

    Elif Ediboglu1, Samuel Falde1, Misbah Baqir1, Rodrigo Cartin-Ceba2 and Ulrich Specks1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Scottsdale, AZ

    Background/Purpose: The association of interstitial lung disease (ILD) and microscopic polyangiitis (MPA) is increasingly recognized. The implications of ILD as it relates to clinical outcomes…
  • Abstract Number: 0693 • ACR Convergence 2024

    Behind the Bronchiectasis in Systemic Sclerosis. Prevalence and Risk Factors

    Miriam Retuerto Guerrero1, Clara Moriano2, Paula Perez Garcia3, cristiana sieiro santos4 and elvira Diez álvarez3, 1Complejo Asistencial Universitario de León, Leon, Spain, 2Hospital León, LEON, Spain, 3Complejo Asistencial Universitario de Leon, Leon, 4Rheumatology Department, Complejo Asistencial Universitario de León, León, Spain, Leon, Spain

    Background/Purpose: Bronchiectasis (BC) has been observed in association with Systemic Sclerosis (SSc). Esophageal dysmotility, immunosuppressive drugs and the direct effect of collagen deposition in the…
  • Abstract Number: 1561 • ACR Convergence 2024

    Association of Large Vessel Vasculitis and Development of SSc and SSc-Associated Antibodies: Impact of Pulmonary Arterial Hypertension

    Brett Dinner1, Ahmed Abdelmaksoud2, Ann Igoe3, Taylor Viggiano4 and Vivek Nagaraja5, 1Creighton University, Paradise Valley, AZ, 2University of California, Riverside, Riverside, CA, 3Flow, Tempe, AZ, 4Mayo Clinic, Phoenix, 5Mayo Clinic Arizona, Scottsdale, AZ

    Background/Purpose: Large vessel vasculitis (LVV) comprises a spectrum of rare, potentially life-threatening disorders, including giant cell arteritis (GCA) and Takayasu's arteritis (TAK), defined by granulomatous…
  • 1
  • 2
  • 3
  • …
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology